DIMENSION(R) RXL PSA FLEX(R) REAGENT CARTRIDGE
FDA premarket approval P000021 · decided 2001-07-05
Approval details
- PMA number
- P000021
- Trade name
- DIMENSION(R) RXL PSA FLEX(R) REAGENT CARTRIDGE
- Generic name
- PROSTATE-SPECIFIC ANTIGEN (PSA) FOR MANAGEMENT OF PROSTATE CANCERS
- Applicant
- Siemens Healthcare Diagnostics
- Date received
- 2000-06-05
- Decision date
- 2001-07-05
- Days to decision
- 395 days
- Decision code
- APPR
- Product code
- LTJ
- Advisory committee
- Immunology
- Expedited review
- No
- Location
- Newark, DE
- Statement
- APPROVAL FOR THE DIMENSION(R) RXL PSA FLEX(R) REAGENT CARTRIDGE. THE DEVICE IS INDICATED FOR THE FOLLOWING: THE PSA METHOD FOR THE DIMENSION(R) CLINICAL CHEMISTRY SYSTEM WITH THE HETEROGENEOUS IMMUNOASSAY MODULE IS AN IN VITRO DIAGNOSTIC TEST INTENDED TO QUANTITATIVELY MEASURE PROSTATE SPECIFIC ANTIGEN (PSA) IN HUMAN SERUM: 1) AS AN AID IN THE DETECTION OF PROSTATE CANCER WHEN USED IN CONJUNCTION WITH DIGITAL RECTAL EXAM (DRE) IN MEN AGED 50 YEARS OR OLDER. PROSTATE BIOPSY IS REQUIRED FOR THE DI
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.